JPH0784481B1 - - Google Patents

Info

Publication number
JPH0784481B1
JPH0784481B1 JP4504624A JP50462492A JPH0784481B1 JP H0784481 B1 JPH0784481 B1 JP H0784481B1 JP 4504624 A JP4504624 A JP 4504624A JP 50462492 A JP50462492 A JP 50462492A JP H0784481 B1 JPH0784481 B1 JP H0784481B1
Authority
JP
Japan
Prior art keywords
rings
carboxymethylmannoglucan
mannopyranose
salt
opened
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4504624A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP4504624A priority Critical patent/JPH0784481B1/ja
Publication of JPH0784481B1 publication Critical patent/JPH0784481B1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0087Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
JP4504624A 1991-02-21 1992-02-21 Pending JPH0784481B1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4504624A JPH0784481B1 (ja) 1991-02-21 1992-02-21

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2754491 1991-02-21
JP36039591 1991-12-27
JP4504624A JPH0784481B1 (ja) 1991-02-21 1992-02-21

Publications (1)

Publication Number Publication Date
JPH0784481B1 true JPH0784481B1 (ja) 1995-09-13

Family

ID=26365480

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4504624A Pending JPH0784481B1 (ja) 1991-02-21 1992-02-21

Country Status (9)

Country Link
US (3) US5567690A (ja)
EP (1) EP0526649B1 (ja)
JP (1) JPH0784481B1 (ja)
AT (1) ATE166361T1 (ja)
CA (1) CA2081025A1 (ja)
DE (1) DE69225542T2 (ja)
DK (1) DK0526649T3 (ja)
ES (1) ES2117664T3 (ja)
WO (1) WO1992014759A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041818B2 (en) 1998-10-30 2006-05-09 Daiichi Pharmaceutical Co., Ltd. DDS compound and method for measurement thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465188B1 (en) * 1990-06-11 2002-10-15 Gilead Sciences, Inc. Nucleic acid ligand complexes
EP0526649B1 (en) * 1991-02-21 1998-05-20 Drug Delivery System Institute, Ltd. Carboxymethylmannoglucan and derivative thereof
WO1994019376A1 (en) * 1993-02-26 1994-09-01 Drug Delivery System Institute, Ltd. Polysaccharide derivative and drug carrier
US8071737B2 (en) * 1995-05-04 2011-12-06 Glead Sciences, Inc. Nucleic acid ligand complexes
DE19524515A1 (de) * 1995-07-05 1997-01-09 Deutsches Krebsforsch Saccharid-Konjugate
TW527183B (en) 1996-06-06 2003-04-11 Daiichi Seiyaku Co Drug complex
TW409058B (en) 1996-06-06 2000-10-21 Daiichi Seiyaku Co Method for preparation of a drug complex
US6387853B1 (en) 1998-03-27 2002-05-14 Bj Services Company Derivatization of polymers and well treatments using the same
EP1080732A4 (en) 1998-05-22 2004-08-25 Daiichi Seiyaku Co DRUG COMPOSITION
CN1133654C (zh) * 1999-08-05 2004-01-07 武汉大学 灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物及其用途和制备方法
CN100457766C (zh) * 2006-09-26 2009-02-04 重庆邮电大学 非天然活性葡聚四糖烷基苷类化合物及其制备方法和应用
CN115746153A (zh) * 2022-11-09 2023-03-07 华东理工大学 环甘露聚糖及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1053718B (it) * 1973-04-04 1981-10-10 Zambeletti Spa L Metodo per prolungare l azione di farmaci attraverso la formazione di composti mcromolecolari
JPS5366442A (en) * 1976-11-18 1978-06-13 Takuma Sasaki Antitumors
JPS5385000A (en) * 1976-12-31 1978-07-26 Akira Misaki Glucan and its preparation
JPS6045163B2 (ja) * 1977-07-01 1985-10-08 協和醗酵工業株式会社 新規組成物
JPS5461112A (en) * 1977-10-24 1979-05-17 Ono Pharmaceut Co Ltd Oncostatic polysaccharide* its preparation* and oncostatic drugs containing it as an effective component
DE3071815D1 (en) * 1980-08-05 1986-12-11 Debat Lab Use of glycosylglucanes in the treatment of infections of the large intestines
US4454289A (en) * 1981-03-06 1984-06-12 Takara Shuzo Co., Ltd. Polysaccharides having anticarcinogenic activity and method for producing same
JPS59124901A (ja) * 1982-12-29 1984-07-19 Dai Ichi Seiyaku Co Ltd 多糖誘導体
JPS61152634A (ja) * 1984-12-27 1986-07-11 Sugiyama Sangyo Kagaku Kenkyusho 固定化生理活性物質の製造法
IL73972A0 (en) * 1984-12-31 1985-03-31 Yeda Res & Dev Agents based on platinum compounds
US4872885A (en) * 1986-02-27 1989-10-10 Kawasaki Jukogyo Kagushiki Kaisha Dispersant for aqueous slurry of carbonaceous solid and aqueous carbonaceous solid slurry composition incorporating said dispersant therein
DE3624307C1 (de) * 1986-07-18 1987-11-12 Agfa Gevaert Ag Vorrichtung zum Aufnehmen und Absetzen von Spulen
GB8713662D0 (en) * 1987-06-11 1987-07-15 Skandigen Ab Hyaluronic acid derivatives
JPS63310827A (ja) * 1987-06-15 1988-12-19 Sanwa Kagaku Kenkyusho Co Ltd ニコチン酸誘導体を主剤とする徐放性製剤
JPH0659409B2 (ja) * 1987-10-06 1994-08-10 義明 本里 架橋グルコマンナンイオン交換体
IT1224421B (it) * 1987-12-29 1990-10-04 Lamberti Flli Spa Galattomannani modificati e realtivo procedimento di preparazione
JPH01190636A (ja) * 1988-01-22 1989-07-31 Green Cross Corp:The 制癌作用物質複合体
US5124363A (en) * 1988-06-08 1992-06-23 Minnesota Mining And Manufacturing Company Aqueous air foams of polyhydroxy polymer
US5026735A (en) * 1988-06-08 1991-06-25 Minnesota Mining And Manufacturing Company Treatment of hazardous materials with aqueous air foam of polyhydroxy polymer
DK0384416T3 (da) * 1989-02-22 1994-02-28 Sanwa Kagaku Kenkyusho Co Farmaceutisk sammensætning indeholdende hydantoinderivat
JP2726520B2 (ja) * 1989-10-20 1998-03-11 名糖産業株式会社 有機磁性複合体
EP0526649B1 (en) * 1991-02-21 1998-05-20 Drug Delivery System Institute, Ltd. Carboxymethylmannoglucan and derivative thereof
JPH0539521A (ja) * 1991-08-02 1993-02-19 Nippon Steel Corp 含クロム溶鋼の脱炭精錬法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041818B2 (en) 1998-10-30 2006-05-09 Daiichi Pharmaceutical Co., Ltd. DDS compound and method for measurement thereof

Also Published As

Publication number Publication date
US5863907A (en) 1999-01-26
WO1992014759A1 (en) 1992-09-03
EP0526649A4 (en) 1993-09-08
DE69225542T2 (de) 1998-09-10
EP0526649A1 (en) 1993-02-10
DK0526649T3 (da) 1998-10-07
ES2117664T3 (es) 1998-08-16
ATE166361T1 (de) 1998-06-15
US5863908A (en) 1999-01-26
EP0526649B1 (en) 1998-05-20
US5567690A (en) 1996-10-22
DE69225542D1 (de) 1998-06-25
CA2081025A1 (en) 1992-08-22

Similar Documents

Publication Publication Date Title
JPH0784481B1 (ja)
IE890933L (en) Arylhydrazones
AP2002002458A0 (en) Compounds for the treatment of ischemia.
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
MY107655A (en) Derivatives of benzofuran,benzothiophene,indole and indolizine,process for their preparation as well as the compositions containing them
GR3023233T3 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
CY2538B1 (en) Tetrahydropyrido compounds
DE69317877D1 (en) 4''-deoxyerythromycinderivate
DE69938192D1 (en) Imidazonaphthyridine
GR970100409A (el) Βελτιωσεις στην προληψη του καρκινου του μαστου και σε σχεση με αυτην
ES8608503A1 (es) Procedimiento para la fabricacion de nuevos derivados de la cumarina
ZA858169B (en) New adamantanamine derivatives,processes for their preparation and drugs in which they are present
PH31395A (en) Bis-naphthalimides for the treatment of cancer.
CA2373634A1 (en) Isophosphoramide mustard analogs and use thereof
TW224461B (ja)
IL89335A (en) 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds
AU2206401A (en) Labelled ascorbic acid derivatives
IE882897L (en) Azachromanes
PL342992A1 (en) New compounds
NZ336321A (en) Use of benzothiophene (raloxifene) for treating breast cancer
MX9707735A (es) Nuevo uso de (s)-adenosil-l-metionina (same).
MX9800129A (es) 2-aminocarbonil-1, 2-bis(metilsulfonil)-1-(substituidas) hidracinas antitumorales.
MX9709683A (es) Uso de derivados de vitamina d4 para tratamiento contra el cancer.